跳转到主要内容
搜索

早期临床

注册

最新资源

精选资源

Upcoming early clinical webinars

网络研讨会

Model Smarter, Not Harder: Introducing Model Designer

2026 年 6 月 30 日, 10:00 – 11:00 AM ET | 2026 年 7 月 2 日, 10:00 – 11:00 AM JST & 10:00 –
网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 7 月 7 日 – 10-11 AM ET/CET/JST
网络研讨会

Building IND-Ready and Investor-Ready Development Programs

2026 年 7 月 9 日 – 10:00 - 11:00am ET

Latest early clinical blogs

在以下活动中与我们的专家会面

All early clinical resources

Building IND-Ready and Investor-Ready Development Programs

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), Webinar

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

Central Nervous System (CNS), Clinical Trials, Modeling and Simulation, Modeling and Simulation - QSP, Blog

Model Smarter, Not Harder: Introducing Model Designer

Certara Products - Phoenix, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

The Case for Simulating Pregnancy

Certara Products - Simcyp, Certara Services, Modeling and Simulation, Modeling and Simulation - PBPK, Press Coverage

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

Biologics, Modeling and Simulation, Modeling and Simulation - QSP, Publication

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Certara Services, Rare and Neglected Diseases, Case Study

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

Biologics, Certara Products - Certara IQ, Modeling and Simulation - QSP, Publication

Certara’s NLME Engine: Setting the Standard for Run Speed and Stability

Certara Products - Phoenix, Fact Sheet

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

Central Nervous System (CNS), Certara Products, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Drug-Drug Interactions (DDI), ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar

Why ask your CRO to use Pinnacle 21 Enterprise?

Certara Products - Pinnacle 21, Blog
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software